Detailed view for Tb927.7.5160

Basic information

TDR Targets ID: 13214
Trypanosoma brucei, deoxyuridine triphosphatase, putative
Source Database / ID:  TriTrypDB  GeneDB

pI: 5.6221 | Length (AA): 287 | MW (Da): 31943 | Paralog Number: 0

Signal peptide: Y | GPI Anchor: | Predicted trans-membrane segments: 0

Druggability Group : DG5

Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable

Pfam domains

PF08761   dUTPase

Gene Ontology

Mouse over links to read term descriptions.
No GO information for this protein.

Metabolic Pathways

Pyrimidine metabolism (KEGG)
Global map (KEGG)

Structural information

Modbase 3D models:

There are 2 models calculated for this protein. More info on these models, including the models themselves is available at: Modbase

Target Beg Target End Template Template Beg Template End Identity Evalue Model Score MPQS zDope
7 287 4dl8 (A) 7 287 99.00 0 1 1.85909 -0.46
16 90 4qgp (A) 0 78 25.00 0 0.11 0.502024 -0.51

Help me make sense of these data.

Target Beg: first modeled residue
Target End: last modeled residue
Template: template structure used for modelling (PDB accession and chain)
Template Beg: first template residue in target-template alignment
Template End: last template residue in target-template alignment
Identity: sequence identity
Evalue: E value for target-template hit
Model Score: GA341 score (>0.7 for reliable model)
MPQS: ModPipe Quality Score (>1.1 for reliable model)
zDope: zDope Score (negative for reliable model)

A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.

PDB Structures:

PDB tag
  • 4DK2:
  • Resolution Method # Atoms # Residues Dep. Date Pub. Date Mod. Date
PDB tag
  • 4DK4:
  • Resolution Method # Atoms # Residues Dep. Date Pub. Date Mod. Date
PDB tag
  • 4DKB:
  • Resolution Method # Atoms # Residues Dep. Date Pub. Date Mod. Date
PDB tag
  • 4DL8:
  • Resolution Method # Atoms # Residues Dep. Date Pub. Date Mod. Date
PDB tag
  • 4DLC:
  • Resolution Method # Atoms # Residues Dep. Date Pub. Date Mod. Date

Expression

Upregulation Percent Ranking Stage Dataset
Upper 80-100% percentile Procyclic, Bloodstream Form. Siegel TN
Show/Hide expression data references
  • Siegel TN Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites.

Orthologs

Ortholog group members (OG5_143192)

Species Accession Gene Product
Leishmania braziliensis LbrM.06.0570   deoxyuridine triphosphatase, putative,dUTP diphosphatase
Leishmania donovani LdBPK_060580.1   deoxyuridine triphosphatase, putative
Leishmania infantum LinJ.06.0580   deoxyuridine triphosphatase, putative,dUTP diphosphatase
Leishmania major LmjF.06.0560   deoxyuridine triphosphatase, putative,dUTP diphosphatase
Leishmania mexicana LmxM.06.0560   deoxyuridine triphosphatase, putative,dUTP diphosphatase
Trypanosoma brucei gambiense Tbg972.7.5940   deoxyuridine triphosphatase, putative,dUTP diphosphatase, putative
Trypanosoma brucei Tb927.7.5160   deoxyuridine triphosphatase, putative
Trypanosoma congolense TcIL3000_7_4360   deoxyuridine triphosphatase, putative
Trypanosoma cruzi TcCLB.508175.160   deoxyuridine triphosphatase, putative
Trypanosoma cruzi TcCLB.509151.130   deoxyuridine triphosphatase, putative

Essentiality

Tb927.7.5160 has direct evidence of essentiality
Gene/Ortholog Organism Phenotype Source Study
Tb927.7.5160 this record Trypanosoma brucei no significant loss or gain of fitness in bloodstream forms (3 days) alsford
Tb927.7.5160 this record Trypanosoma brucei no significant loss or gain of fitness in bloodstream forms (6 days) alsford
Tb927.7.5160 this record Trypanosoma brucei no significant loss or gain of fitness in procyclic forms alsford
Tb927.7.5160 this record Trypanosoma brucei significant loss of fitness in differentiation of procyclic to bloodstream forms alsford
Show/Hide essentiality data references
  • keio Systematic single-gene knock-out mutants of E. coli K12 The Keio Collection
  • gerdes Experimental determination and system-level analysis of essential genes in E. coli MG1655 Gerdes et al., J Bacteriol. 2003 185:5673-84
  • alsford High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome Genome Res 2011, 21:915-924
  • nmpdr Genome-scale essentiality datasets from published studies (M. tuberculosis) National Microbial Pathogen Data Resource
  • neb C. elegans RNAi phenotypes Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs
  • sidik A Genome-wide CRISPR Screen in Toxoplasma Identifies Essential Apicomplexan Genes. Sidik, Saima M., et al. "A genome-wide CRISPR screen in toxoplasma identifies essential apicomplexan genes." Cell 166.6 (2016): 1423-1435.
  • goodall The Essential Genome of Escherichia coli K-12 (Transposon directed high-throughput mutagenesis) Goodall, Emily CA, et al. "The essential genome of Escherichia coli K-12." mBio 9.1 (2018): e02096-17.
  • wormbase C. elegans RNAi experiments WormBase web site, http://www.wormbase.org, release WS170
  • blattner Systematic mutagenesis of the E. coli (MG1655) genome J Bacteriol 2004, 186:4921-4930
  • yeastgenome Systematic deletion of yeast genes Saccharomyces Genome Database
  • plasmo Functional Profiling of a Plasmodium Genome Reveals an Abundance of Essential Genes. Bushell, Ellen, et al. "Functional profiling of a Plasmodium genome reveals an abundance of essential genes." Cell 170.2 (2017): 260-272.
  • shigen Profiling of E. coli Chromosome (PEC) National Institute of Genetics, Japan

Phenotypes and Validation (curated)

Annotated phenotypes:

Affected Entity Phenotypic quality Occurs in Occurs at Evidence Observed in Drugs/Inhibitors
cell proliferation (GO:0008283) normal (PATO:0000461) bloodstream stage trypomastigotes (PLO:0027) inferred from RNAi experiment (ECO:0000019) No drug identifiers listed for this gene.
Annotator: fernan@iib.unsam.edu.ar. Comment: normal cell proliferation (no significant loss or gain of fitness) in bloodstream forms (stage 6 days). References: 21363968
cell proliferation (GO:0008283) normal (PATO:0000461) procyclic (PLO:0034) inferred from RNAi experiment (ECO:0000019) No drug identifiers listed for this gene.
Annotator: fernan@iib.unsam.edu.ar. Comment: normal cell proliferation (no significant loss or gain of fitness) in procyclic forms . References: 21363968
cell proliferation (GO:0008283) decreased (PATO:0000468) procyclic (PLO:0034) inferred from RNAi experiment (ECO:0000019) No drug identifiers listed for this gene.
Annotator: fernan@iib.unsam.edu.ar. Comment: decreased cell proliferation (significant loss of fitness) in differentiation of procyclic to bloodstream forms . References: 21363968

In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.

In any case, if you have information about papers containing relevant validation data for this target, please contact us.

Annotated validation

No validation data for this target

Associated compounds / Druggability

Druggability index (range: 0 to 1): 0.2

Known modulators for this target

No chemical compounds associated to this gene

Predicted associations

By orthology with druggable targets
Species Known druggable target Linked compounds Reference
Trypanosoma cruzi deoxyuridine triphosphatase, putative Compounds References
By sequence similarity to non orthologous druggable targets
No additional associated druggable targets
Obtained from network model

Ranking Plot

Putative Drugs List

Compound Raw Global Species
0.0348 0.3019 0.3005
0.0357 0.3038 0.3022
0.0352 0.3027 0.3013
0.0352 0.5134 0.5099
0.0349 0.2665 0.2665
0.0348 0.3019 0.3005
0.0369 0.3745 0.3731
0.0357 0.3038 0.3022
0.0355 0.3538 0.3531
0.0353 0.2735 0.5393
0.0346 0.265 0.2649
0.035 0.3569 0.3568
0.0346 0.2669 0.2669
0.0347 0.5523 0.5523
0.0346 0.5319 0.5319
0.0362 0.2518 0.2667
0.0346 0.3021 0.3005
0.0362 0.2594 0.3044
0.0346 0.3051 0.3003
0.048285 0.746538 0.746498
0.0348 0.3005 0.3005
0.048285 0.746538 0.746498
0.0352 0.5435 0.5316
0.0352 0.3037 0.303
0.0359 0.2692 0.2665
0.035 0.3023 0.3006
0.0355 0.2676 0.2638
0.0362 0.2675 0.2672
0.035 0.3063 0.3021
0.048285 0.746538 0.746498
0.0355 0.3064 0.3021
0.0348 0.3553 0.3507
0.0348 0.3537 0.3535
0.0348 0.3517 0.3497
0.035 0.4669 0.3844
0.0362 0.2675 0.2672
0.0352 0.3021 0.3021
0.0348 0.3021 0.3005
0.0352 0.3037 0.3018
0.0346 0.2669 0.2669

Assayability

Assay information

No assay information for this target.

Reagent availability

No reagent availability information for this target.

Bibliographic References

10 literature references were collected for this gene.

If you have references for this gene, please enter them in a user comment (below) or Contact us.

User comments

No user comments are available for this gene. Log in to add comments, or register.

Enter your comment

User ()
Gene identifier Tb927.7.5160 (Trypanosoma brucei), deoxyuridine triphosphatase, putative
Title for this comment
Comment